Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the incidence of post-operative residual curarization in our patients and to determine if Cisatracurium and Rocuronium behave differently from each other in t...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Azienda Ospedaliera di Padova
NCT07080528 · Neuromuscular Blocking Agents, Residual Neuromuscular Block, and more
NCT07309393 · Residual Neuromuscular Block
NCT03923556 · Kidney Transplant; Complications, Postoperative Residual Curarization, and more
NCT06517524 · Residual Neuromuscular Block, Cardiovascular Diseases, and more
NCT05992090 · Neuromuscular Blockade, Residual Neuromuscular Blockade
Azienda Ospedaliera di Padova
Padova, Padova
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions